HMGCR and diabetes mellitus: Moreover, recent studies have suggested that use of statin drugs in dyslipidaemia can actually provoke new-onset diabetes in ‘prediabetic’ patients [77], and genetic variants in HMGCR have also been linked with predisposition to diabetes, again positing cholesterol biosynthesis as important in sustaining beta cell function [100].